First human tests begin for potential blood cancer treatment
NCT ID NCT06399315
Summary
This early-stage study tested a new drug called ZE46-0134 in healthy volunteers to check its safety and how the body processes it. Researchers gave different doses to 112 healthy adults to monitor for side effects and measure drug levels in the blood. The study was completed and provides initial safety data before testing in patients with acute myeloid leukemia (AML).
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AML are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Linear Clinical Research Ltd
Perth, Nedlands, WA 6009, Australia
Conditions
Explore the condition pages connected to this study.